Education
About Us
Working with TipRanks
Follow Us
Amphastar Pharmaceuticals Inc (AMPH)
:AMPH
AMPH Analyst Ratings
Moderate Buy
2 Buy
3 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
AMPH Stock 12 Month Forecast
Average Price Target
$38.25
▲(34.73% Upside)
| Highest Price Target$45.00 | Average Price Target$38.25 | Lowest Price Target$32.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Piper Sandler
Reiterated
03/21/25
Bank of America Securities
Reiterated
02/28/25
Needham
Reiterated
02/28/25
Wells Fargo
Reiterated
02/28/25
J.P. Morgan
Reiterated
02/14/25
Capital One Financial
$70
Buy
146.57%
Upside
Assigned
10/18/24
Amphastar Pharmaceuticals: Strong Product Pipeline and Financial Position Justify Buy Rating
Jefferies
$62→$55
Buy
93.73%
Upside
Reiterated
08/12/24
Amphastar Pharmaceuticals (AMPH) PT Lowered to $55 at JefferiesJefferies analyst Glen Santangelo lowered the price target on Amphastar Pharmaceuticals (NASDAQ: AMPH) to $55.00 (from $62.00) while maintaining a Buy rating.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Piper Sandler
Reiterated
03/21/25
Bank of America Securities
Reiterated
02/28/25
Needham
Reiterated
02/28/25
Wells Fargo
Reiterated
02/28/25
J.P. Morgan
Reiterated
02/14/25
Capital One Financial
$70
Buy
146.57%
Upside
Assigned
10/18/24
Amphastar Pharmaceuticals: Strong Product Pipeline and Financial Position Justify Buy Rating
Jefferies
$62→$55
Buy
93.73%
Upside
Reiterated
08/12/24
Amphastar Pharmaceuticals (AMPH) PT Lowered to $55 at JefferiesJefferies analyst Glen Santangelo lowered the price target on Amphastar Pharmaceuticals (NASDAQ: AMPH) to $55.00 (from $62.00) while maintaining a Buy rating.
AMPH Analyst Recommendation Trends
Rating
Aug 24
Oct 24
Nov 24
Feb 25
Mar 25
Strong Buy
4
3
2
0
0
Buy
2
3
5
5
4
Hold
3
3
3
6
7
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
9
9
10
11
11
Each month's total comprises the sum of three months' worth of ratings.
AMPH Financial Forecast
AMPH Stock Forecast FAQ
What is AMPH’s average 12-month price target, according to analysts?
Based on analyst ratings, Amphastar Pharmaceuticals Inc’s 12-month average price target is $38.25.
What is AMPH’s upside potential, based on the analysts’ average price target?
Amphastar Pharmaceuticals Inc has 34.73% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is AMPH a Buy, Sell or Hold?
Amphastar Pharmaceuticals Inc has a consensus rating of Moderate Buy which is based on 2 buy ratings, 3 hold ratings and 0 sell ratings.
What is Amphastar Pharmaceuticals Inc’s price target?
The average price target for Amphastar Pharmaceuticals Inc is $38.25. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $45.00 ,the lowest forecast is $32.00. The average price target represents 34.73% Increase from the current price of $28.39.
The highest analyst price target is $45.00 ,the lowest forecast is $32.00. The average price target represents 34.73% Increase from the current price of $28.39.
What do analysts say about Amphastar Pharmaceuticals Inc?
Amphastar Pharmaceuticals Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 5 Wall Streets Analysts.
How can I buy shares of AMPH?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.